ClearPoint Neuro 

$13.48
261
+$0.04+0.3% Today

Statistics

Day High
14.04
Day Low
13.24
52W High
30.1
52W Low
8.27
Volume
15,438,598
Avg. Volume
-
Mkt Cap
383.14M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.32
-0.27
-0.21
-0.16
Expected EPS
-0.286667
Actual EPS
N/A

Financials

-60.25%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
62.78MRevenue
-37.83MNet Income

Analyst Ratings

20.00Average Price Target
The highest estimate is 20.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CLPT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap145.58B
Intuitive Surgical is a competitor because it specializes in robotic-assisted surgeries, a field where ClearPoint Neuro's precision navigation and therapy delivery systems could be applied.
Medtronic
MDT
Mkt Cap102.97B
Medtronic competes in the neurosurgery space with its own range of surgical navigation systems and robotics, directly competing with ClearPoint Neuro's offerings.
Smith & Nephew
SNN
Mkt Cap12.95B
Smith & Nephew operates in the advanced surgical and robotics field, overlapping with ClearPoint Neuro's market in neurosurgery and precision therapeutic applications.
Zimmer Biomet
ZBH
Mkt Cap17.13B
Zimmer Biomet Holdings, Inc. competes in the area of surgical solutions, including technologies that could be used in neurosurgical procedures, a direct competition to ClearPoint Neuro.
Boston Scientific
BSX
Mkt Cap69.72B
Boston Scientific Corporation offers products in neuromodulation, competing with ClearPoint Neuro in the broader neurosurgical equipment and technology market.
Globus Medical
GMED
Mkt Cap10.91B
Globus Medical, Inc. competes with its advancements in musculoskeletal solutions and minimally invasive surgical technologies, which can be applied to neurosurgery, overlapping with ClearPoint Neuro's market.
Stryker
SYK
Mkt Cap119.69B
Stryker Corporation is a competitor due to its neurotechnology and spine division, offering products that compete with ClearPoint Neuro's neurosurgical navigation and therapy delivery systems.
NovoCure
NVCR
Mkt Cap2.06B
NovoCure operates with its Tumor Treating Fields technology, a novel therapy that competes with ClearPoint Neuro's targeted therapeutic delivery systems for brain conditions.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie, through its acquisition of Allergan, competes in the neuroscience space, including therapies for neurological disorders, potentially competing with ClearPoint Neuro's therapeutic applications.
Pfizer
PFE
Mkt Cap149.38B
Pfizer is involved in the development of treatments for neurological conditions, which could compete with ClearPoint Neuro's focus on delivering therapies directly to the brain.

About

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
Show more...
CEO
Mr. Joseph Michael Burnett
Employees
115
Country
United States
ISIN
US18507C1036

Listings

0 Comments

Share your thoughts

FAQ

What is ClearPoint Neuro stock price today?
The current price of CLPT is $13.48 USD — it has increased by +0.3% in the past 24 hours. Watch ClearPoint Neuro stock price performance more closely on the chart.
What is ClearPoint Neuro stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange ClearPoint Neuro stocks are traded under the ticker CLPT.
Is ClearPoint Neuro stock price growing?
CLPT stock has risen by +0.15% compared to the previous week, the month change is a +15.12% rise, over the last year ClearPoint Neuro has showed a +16.12% increase.
What is ClearPoint Neuro market cap?
Today ClearPoint Neuro has the market capitalization of 383.14M
When is the next ClearPoint Neuro earnings date?
ClearPoint Neuro is going to release the next earnings report on August 11, 2026.
What were ClearPoint Neuro earnings last quarter?
CLPT earnings for the last quarter are -0.32 USD per share, whereas the estimation was -0.27 USD resulting in a -17.07% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ClearPoint Neuro revenue for the last year?
ClearPoint Neuro revenue for the last year amounts to 62.78M USD.
What is ClearPoint Neuro net income for the last year?
CLPT net income for the last year is -37.83M USD.
How many employees does ClearPoint Neuro have?
As of June 15, 2026, the company has 115 employees.
In which sector is ClearPoint Neuro located?
ClearPoint Neuro operates in the Health & Wellness sector.
When did ClearPoint Neuro complete a stock split?
The last stock split for ClearPoint Neuro was on July 27, 2016 with a ratio of 1:40.
Where is ClearPoint Neuro headquartered?
ClearPoint Neuro is headquartered in Solana Beach, United States.